Product Description

DerMax® is CE approved as a Class IIb medical device manufactured by Dermagenics and currently approved for use and available in Europe and the Middle East. DerMax® is a sterile wound dressing composed of an acetate carrier impregnated with a proprietary ointment which will be released to the wound surface after the dressing is applied to the wound.

Dermax® is intended for use with chronic wounds. Dermax® normalizes the wound micro-environment by reducing excessive inflammation, thereby facilitating re-epithelialization of the wound.

Indications

DerMax® should be used on problematic chronic wounds or on wounds where a faster and easier healing process is desired, including the following types of wounds:

Acute severe wounds:

• Burns
• Surgical wounds
• Traumatic wounds
• Other acute wounds where fast epithelialization is required

Chronic severe wounds

• Leg ulcers
• Diabetic ulcers
• Decubitus ulcers